Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 1
Submit an article Journal homepage
433
Views
1
CrossRef citations to date
0
Altmetric
Author's View

Membrane-bound KIT ligand-targeting DNA vaccination inhibits mammary tumor growth

Patrizia Dentelli Department of Medical Sciences; University of Torino; Torino, Italy
,
Federica Cavallo Molecular Biotechnology Center; University of Torino; Torino, ItalyCorrespondence[email protected] [email protected]
&
Maria Felice Brizzi Department of Medical Sciences; University of Torino; Torino, ItalyCorrespondence[email protected] [email protected]
Article: e27259 | Received 18 Nov 2013, Accepted 18 Nov 2013, Published online: 01 Jan 2014

References

  • Miyazawa K, Williams DA, Gotoh A, Nishimaki J, Broxmeyer HE, Toyama K. Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood 1995; 85:641 - 9; PMID: 7530502
  • Dentelli P, Rosso A, Balsamo A, Colmenares Benedetto S, Zeoli A, Pegoraro M, Camussi G, Pegoraro L, Brizzi MF. C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium. Blood 2007; 109:4264 - 71; http://dx.doi.org/10.1182/blood-2006-06-029603; PMID: 17289809
  • Defilippi P, Rosso A, Dentelli P, Calvi C, Garbarino G, Tarone G, Pegoraro L, Brizzi MF. beta1 Integrin and IL-3R coordinately regulate STAT5 activation and anchorage-dependent proliferation. J Cell Biol 2005; 168:1099 - 108; http://dx.doi.org/10.1083/jcb.200405116; PMID: 15795318
  • Dentelli P, Rosso A, Olgasi C, Camussi G, Brizzi MF. IL-3 is a novel target to interfere with tumor vasculature. Oncogene 2011; 30:4930 - 40; http://dx.doi.org/10.1038/onc.2011.204; PMID: 21643009
  • Chew HK, Barlow WE, Albain K, Lew D, Gown A, Hayes DF, Gralow J, Hortobagyi GN, Livingston R. A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338. Clin Breast Cancer 2008; 8:511 - 5; http://dx.doi.org/10.3816/CBC.2008.n.062; PMID: 19073506
  • Cavallo F, De Giovanni C, Nanni P, Forni G, Lollini PL. 2011: the immune hallmarks of cancer. Cancer Immunol Immunother 2011; 60:319 - 26; http://dx.doi.org/10.1007/s00262-010-0968-0; PMID: 21267721
  • Holmgren L, Ambrosino E, Birot O, Tullus C, Veitonmäki N, Levchenko T, Carlson LM, Musiani P, Iezzi M, Curcio C, et al. A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. Proc Natl Acad Sci U S A 2006; 103:9208 - 13; http://dx.doi.org/10.1073/pnas.0603110103; PMID: 16754857
  • Arigoni M, Barutello G, Lanzardo S, Longo D, Aime S, Curcio C, Iezzi M, Zheng Y, Barkefors I, Holmgren L, et al. A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. Angiogenesis 2012; 15:305 - 16; http://dx.doi.org/10.1007/s10456-012-9263-3; PMID: 22426512
  • Haller BK, Bråve A, Wallgard E, Roswall P, Sunkari VG, Mattson U, Hallengärd D, Catrina SB, Hellström M, Pietras K. Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma. Oncogene 2010; 29:4276 - 86; http://dx.doi.org/10.1038/onc.2010.176; PMID: 20498640
  • Olgasi C, Dentelli P, Rosso A, Iavello A, Togliatto G, Toto V, Liberatore M, Barutello G, Musiani P, Cavallo F, et al. DNA vaccination against membrane-bound Kit ligand: A new approach to inhibiting tumour growth and angiogenesis. Eur J Cancer 2013; Forthcoming http://dx.doi.org/10.1016/j.ejca.2013.09.016; PMID: 24144734

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.